← Eichor
Study identifier: NCT06155682 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

TMS for Inhibition Enhancement in Schizophrenia

Condition: Schizophrenia  ·  Sponsor: University of Maryland, Baltimore

PhaseNA
Planned participants34
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersNo

About this study

This study purpose is to perform a pilot mechanistic trial repetitive transcranial magnetic stimulation (rTMS) clinical trial in 34 people with schizophrenia (Sz). The trial will evaluate whether inhibitory 1 Hertz (Hz) rTMS targeting motor cortex can increase brain inhibition reflected in a decrease in the short-interval intracortical inhibition (SICI) score from pre-to-post-treatment. We will also collect preliminary data on the effect of rTMS on the resting functional connectivity of the motor cortex and other brain regions and the relationship of change in SICI to change in cognitive performance

This description comes directly from the study's public registry record.

Talk to the study team

Stephanie Hare, PhD  ·  410-402-6119  ·  stephanie.hare@som.umaryland.edu

Jennifer Zaranski  ·  jzaranski@som.umaryland.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Maryland Psychiatric Research CenterCatonsville, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06155682